HALO logo
halo search icon
Tarsus Pharmaceuticals, Inc.

US$63.48

Price Change Indicator
-1.31 (-2.022%)
Tarsus Pharmaceuticals, Inc.
TARS · NAS

Tarsus Pharmaceuticals, Inc.

Start Trading TARS for Free

US$63.48

Price Arrow-1.31 (-2.022%)
21/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusConsensus CheapEMA 125 BreakdownHALO All
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Tarsus Pharmaceuticals, Inc. Overview

TARS Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Weak

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About TARS

icon
icon

Telephone

1.949.409.9820

icon

Address

Suite 160, 15440 Laguna Canyon Road, Irvine, CA 92618

Description

Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of therapeutic candidates. Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as Demodex blepharitis. It is also developing TP-04 for the potential treatment of Ocular Rosacea and TP-05 as an oral tablet for the potential prevention of Lyme disease. The company was founded by Bobak Azamian and D. Michael Ackermann in 2017 and is headquartered in Irvine, CA.

TARS Price Chart

Key Stats

Market Cap

US$2.79B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 38.51 - 85.25

Trade Value (12mth)

US$9,417,113.00

1 week

3.7%

1 month

2.06%

YTD

-19.78%

1 year

50.78%

All time high

85.25

Key Fundamentals

EPS 3 yr Growth

-37.00%

EBITDA Margin

-15.30%

Operating Cashflow

-$12m

Free Cash Flow Return

-3.40%

ROIC

-18.40%

Interest Coverage

-7.70

Quick Ratio

3.80

Other Data

Shares Outstanding (Fully Diluted)

43m

HALO Sector

Healthcare

Next Company Report Date

02-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

TARS Announcements

Latest Announcements

DateAnnouncements
07 May 26
07 May 26
07 May 26
07 May 26
07 May 26

TARS Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-4.62-3.07-1.59locklocklock
EPS (Fully Diluted)
 $locklocklocklock-4.62-3.07-1.59locklocklock
Growth
 %locklocklocklock-83.433.648.3locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Tarsus Pharmaceuticals, Inc. (TARS:NAS)?
Halo FAQ
The current share price of Tarsus Pharmaceuticals, Inc. (TARS:NAS) is USD$63.48.
What is the 52-week high share price for Tarsus Pharmaceuticals, Inc. (TARS:NAS)?
Halo FAQ
The 52-week high share price for Tarsus Pharmaceuticals, Inc. (TARS:NAS) is USD$85.25.
What is the 52-week low share price for Tarsus Pharmaceuticals, Inc. (TARS:NAS)?
Halo FAQ
The 52-week low share price for Tarsus Pharmaceuticals, Inc. (TARS:NAS) is USD$38.51.
What is the dividend yield for Tarsus Pharmaceuticals, Inc. (TARS:NAS)?
Halo FAQ
Tarsus Pharmaceuticals, Inc. (TARS:NAS) does not pay a dividend.
What was Tarsus Pharmaceuticals, Inc. (TARS:NAS) last dividend payment?
Halo FAQ
Tarsus Pharmaceuticals, Inc. (TARS:NAS) does not pay a dividend.
What is the franking level for Tarsus Pharmaceuticals, Inc. (TARS:NAS)?
Halo FAQ
Tarsus Pharmaceuticals, Inc. (TARS:NAS) has a franking level of 0.00%.
In which sector is Tarsus Pharmaceuticals, Inc. (TARS:NAS) classified?
Halo FAQ
Tarsus Pharmaceuticals, Inc. (TARS:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial